This inventor holds 1 USPTO granted patent. Top assignees: Samsung Life Public Welfare Foundation, Sungkyunkwan University. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2017
Title: Jae Myoung Noh: Innovator in Biocompatible Fiducial Markers
Introduction
Jae Myoung Noh is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical technology, particularly in the development of biocompatible fiducial markers. His innovative work addresses critical challenges in imaging and therapeutic applications.
Latest Patents
Jae Myoung Noh holds a patent for a biocompatible fiducial marker using multi-block copolymers. This invention comprises barium sulfate (BaSO), a solvent, and a polyethylene glycol-poly(aminourethaneurea) multi-block copolymer as active ingredients. The fiducial marker significantly remedies disadvantages of image distortion and dose distortion associated with conventional gold inner markers. It exhibits very limited in vivo mobility, ensuring that it remains at the position where it has been initially injected. The marker is maintained in a sol or liquid state before injection and transitions into a gel or solid phase afterward, allowing for favorable injectability by an injector syringe.
Career Highlights
Throughout his career, Jae Myoung Noh has worked with notable organizations, including the Samsung Life Public Welfare Foundation and Sungkyunkwan University. His experience in these institutions has contributed to his expertise in the field of medical innovations.
Collaborations
Jae Myoung Noh has collaborated with esteemed colleagues such as Young Yih Han and Hee Chul Park. These partnerships have further enhanced his research and development efforts in biocompatible technologies.
Conclusion
Jae Myoung Noh's contributions to the field of biocompatible fiducial markers demonstrate his commitment to advancing medical technology. His innovative solutions address significant challenges in imaging and therapeutic applications, making a lasting impact in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile